Globus Medical, Inc.
GMED
$91.04
-$0.04-0.04%
NYSE
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 11.75% | 17.43% | 32.26% | 60.62% | 102.10% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 11.75% | 17.43% | 32.26% | 60.62% | 102.10% |
| Cost of Revenue | -3.30% | 16.17% | 53.81% | 88.53% | 163.56% |
| Gross Profit | 20.80% | 18.13% | 21.99% | 47.74% | 77.23% |
| SG&A Expenses | 14.83% | 17.34% | 27.25% | 52.02% | 87.60% |
| Depreciation & Amortization | 0.99% | 17.49% | 55.70% | 133.92% | 328.90% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.54% | 13.58% | 34.76% | 66.92% | 122.37% |
| Operating Income | 76.22% | 44.57% | 18.08% | 28.11% | 17.78% |
| Income Before Tax | 280.43% | 461.28% | 148.76% | -27.01% | -40.23% |
| Income Tax Expenses | 24.33% | -34.73% | 75.38% | -58.28% | -33.79% |
| Earnings from Continuing Operations | 363.08% | 776.83% | 178.51% | -16.19% | -42.05% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 363.08% | 776.83% | 178.51% | -16.19% | -42.05% |
| EBIT | 76.22% | 44.57% | 18.08% | 28.11% | 17.78% |
| EBITDA | 43.19% | 33.29% | 28.87% | 45.43% | 63.77% |
| EPS Basic | 364.81% | 775.77% | 112.87% | -35.88% | -57.22% |
| Normalized Basic EPS | 64.70% | 33.69% | -5.38% | -19.09% | -18.84% |
| EPS Diluted | 368.77% | 796.24% | 112.66% | -35.72% | -57.31% |
| Normalized Diluted EPS | 63.97% | 32.59% | -6.30% | -19.05% | -18.14% |
| Average Basic Shares Outstanding | -0.16% | 4.28% | 11.73% | 20.09% | 31.36% |
| Average Diluted Shares Outstanding | 0.36% | 5.21% | 12.84% | 20.05% | 30.37% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |